Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Treatment Efficacy of High-Dose Corticosteroid and Tocilizumab During Clinical Worsening in Patients With COVID-19 Pneumonia

NCT05133635 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT05133635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05133635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Treatment Efficacy of High-Dose Corticosteroid and Tocilizumab During Clinical Worsening in Patients With COVID-19 Pneumonia
Lead sponsor
Marmara University
Phase
Phase 4
Overall status
Withdrawn
Start date
February 1, 2021
Completion date
April 1, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

corticosteroid, covid-19 virus infection, cytokine storm, tocilizumab